13F-HR filed by Redmile Group, LLC
Redmile Group, LLC filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-15, with 64 holding rows worth $1,642,718,000.
- Accession
- 0001425738-17-000014
- Filer
- CIK 1425738
- Filed
- 2017-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 64 entries on the cover page, a total value of $1,642,718,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,642,718,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 16,093,786 | $134,705,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 12,043,932 | $121,282,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 931,444 | $81,734,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 860,456 | $75,204,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 764,389 | $71,570,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 2,219,616 | $66,344,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 828,574 | $57,321,000 | thousands by filing date | |
| INC RESH HLDGS INC | 45329R109 | CL A | 841,418 | $49,223,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 444,936 | $44,605,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 231,886 | $43,625,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 2,224,407 | $41,374,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 2,734,044 | $38,277,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 5,212,736 | $37,063,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 2,155,949 | $36,263,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 681,165 | $35,046,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 665,139 | $34,414,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 1,718,671 | $33,944,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 398,200 | $31,808,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 6,368,299 | $30,950,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,094,983 | $30,353,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 1,459,616 | $27,922,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 509,698 | $27,585,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 218,000 | $25,776,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC | 04269XAA3 | NOTE 3.000% 6/0 | 19,000,000 | $25,656,000 | thousands by filing date | principal |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 2,223,811 | $25,463,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,187,494 | $25,068,000 | thousands by filing date | |
| SPECTRANETICS CORP | 84760C107 | COM | 634,802 | $24,376,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 1,223,334 | $22,999,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 4,207,575 | $22,931,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 132,505 | $22,857,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 713,280 | $21,234,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 476,341 | $20,240,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 367,537 | $18,623,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 144,408 | $18,610,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 631,283 | $17,266,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 555,096 | $16,597,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 657,356 | $16,480,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 1,138,370 | $15,971,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 973,260 | $15,660,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 866,819 | $14,337,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 152,000 | $14,232,000 | thousands by filing date | call |
| CASCADIAN THERAPEUTICS INC | 14740B606 | COM NEW | 3,735,994 | $13,879,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 212,028 | $12,978,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 858,314 | $11,416,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 698,392 | $10,825,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V907 | COM | 101,500 | $8,871,000 | thousands by filing date | call |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,596,275 | $8,301,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 812,240 | $7,765,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 599,620 | $6,692,000 | thousands by filing date | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 225,040 | $6,526,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 145,963 | $5,123,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,419,058 | $4,598,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 448,781 | $4,237,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 94,560 | $2,564,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 332,310 | $2,037,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 1,820 | $337,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 6,640 | $305,000 | thousands by filing date | |
| ALLERGAN PLC | G0177J108 | SHS | 1,200 | $292,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 14,580 | $285,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 12,380 | $212,000 | thousands by filing date | |
| AMEDISYS INC | 023436108 | COM | 3,356 | $211,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 12,110 | $178,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 22,236 | $56,000 | thousands by filing date | |
| CASTLIGHT HEALTH INC CL B | 14862Q100 | Stock | 10,229 | $42,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001425738-17-000014 | this filing | 2017-08-15 | acceptance time not in the bulk data set |